ABSTRACT
Objective To examine the impact of psychosocial factors on physical activity,so as to provide guidance for the development of an effective physical activity intervention program for individuals with hypertension.Methods This study used a baseline data from an intervention study on regular physical activity among hypertensive individuals.A multi-stage,stratified random sampling was utilized and finally 12 communities from 6 urban districts were chosen.Questionnaires were administrated through face-to-face interviews.A total of 586 participants were recruited and finally 559 completed the interviews with the response rate as 95.4%.Descriptive statistics and Cronbach' sα coefficients were used to test the reliability.General Linear Model analysis was used to analyze the relationship between stages of physical activity and psychological factors.Results Psychosocial measures on physical activity demonstrated good reliability with Cronbach α coefficient from 0.7 to 0.9.The scores for each psychological measures increased by increasing the scores of stages of physical activity.General Linear Model analysis revealed self-efficacy (β=0.379) while enjoyment of physical activity (β =0.234) was significantly correlated with physical activity (P<0.05).The behavioral processes and family support marginally increased the physically activity (β =0.069 for behavioral processes and β=0.163 for family support,P<0.10).Conclusion Our findings were informative for the development of community-based intervention programs on physical activity among hypertensive individuals.It indicated that physical activity intervention programs should be psychosocial theory-based,especially increasing their self-confidence and enjoyment,as well as with family support,in order to adopt and maintain the physical activities.
ABSTRACT
<p><b>BACKGROUND</b>Studies have confirmed that angiotensin II receptor blocker (ARB) and angiotensin converting enzyme inhibitors (ACEI) in the treatment of diabetic nephropathy (DN) has special advantages. We observed the effects of valsartan and metoprolol tartrate hydrchloride in treatment of DN patients with positive β1-adrenergic and anti-angiotensin II type 1 (AT1) receptor antibody.</p><p><b>METHODS</b>The epitopes of the second extracellular loop of β1 receptor (197 - 222) and AT1 receptor (165 - 191), were synthesized and used respectively to screen serum autoantibodies from patients with DN (n = 371, group A), diabetes mellitus (DM) without renal failure (n = 107, group B) and healthy blood donors (n = 47, control, group C) by enzyme-linked immunosorbent assay (ELISA). Metoprolol tartrate 25 - 50 mg, three times per day, valsartan 160 mg, once a day, aspirin 100 mg, once a day, and nitrendipine 10 - 20 mg, three times per day, were given to DN patients with positive or negative autoantibodies. The cystatin C level and 24-hour urinary protein were measured before and after treatment.</p><p><b>RESULTS</b>In DN patients, the positive rate of the autoantibodies against β1 receptors and AT1 receptor was 47.7% and 51.5%, respectively, which were significantly higher than those in DM patients and healthy controls (all P < 0.01). Patients with anormalous cystatin C had higher positive rates of the autoantibodies than patients with normal cystatin C. Valsartan and metoprolol tartrate reduced proteinuria significantly (P < 0.01) in DN patients with positive autoantibodies.</p><p><b>CONCLUSIONS</b>The findings suggest that these autoantibodies against β1 and AT1-receptor may play important roles in the pathogenesis of DN. Valsartan and metoprolol tartrate are effective and safe in the treatment of DN.</p>
Subject(s)
Aged , Female , Humans , Male , Autoantibodies , Allergy and Immunology , Diabetic Nephropathies , Drug Therapy , Allergy and Immunology , Enzyme-Linked Immunosorbent Assay , Metoprolol , Therapeutic Uses , Receptor, Angiotensin, Type 1 , Allergy and Immunology , Receptors, Adrenergic, beta-1 , Allergy and Immunology , Tetrazoles , Therapeutic Uses , Valine , Therapeutic Uses , ValsartanABSTRACT
<p><b>OBJECTIVE</b>To observe the positive rates of autoantibodies against beta1 adrenergic receptors (beta1-receptor) and angiotensin II type 1 receptors (AT(1)-receptor) in type 2 diabetes patients with or without hypertension.</p><p><b>METHODS</b>The epitopes of the second extracellular loop of beta1-receptor (197 - 222) and AT(1) receptor (165 - 191) were synthesized and serum autoantibodies were determined in type 2 diabetes patients with hypertension (n = 171) or without hypertension (n = 106). Left ventricular dimension was determined by echocardiography. The 24-hour urinary protein was measured by ELISA. The risk factors for enlarged left ventricle were analyzed by multiple logistic regressions.</p><p><b>RESULTS</b>The positive rates of the autoantibodies against beta1-receptors (45.0%) and AT(1)-receptor (46.2%) in patients with type 2 diabetes with hypertension were significantly higher than those in patients with type 2 diabetes without hypertension (16.0% and 10.4%, respectively, all P < 0.01). In type 2 diabetes patients with hypertension and enlarged left ventricle, the positive rates of the autoantibodies against beta1-receptor 61.4% (35/57) and against AT(1)-receptor 64.9% (37/57)were significantly higher than those in type 2 diabetes patients with normal left ventricular dimension (36.8%, 42/114 and 36.8%, 42/114, respectively, all P < 0.01). Regression analysis demonstrated that course of disease, systolic pressure, serum autoantibodies against beta1 adrenergic receptor and angiotensin II type 1 receptors sera autoantibodies were independent risk factors for left ventricular enlargement (all P < 0.05).</p><p><b>CONCLUSION</b>The serum beta1 and AT(1)-receptor autoantibodies are related to enlarged left ventricle in type 2 diabetes patients with hypertension and suggest that autoantibodies against beta1 and AT(1)-receptor might play important roles in the pathogenesis of type 2 diabetes patients with hypertension and enlarged left ventricle.</p>
Subject(s)
Aged , Female , Humans , Male , Middle Aged , Autoantibodies , Blood , Diabetes Mellitus, Type 2 , Allergy and Immunology , Hypertrophy, Left Ventricular , Allergy and Immunology , Receptor, Angiotensin, Type 1 , Allergy and Immunology , Receptors, Adrenergic, beta-1 , Allergy and ImmunologyABSTRACT
<p><b>OBJECTIVE</b>To explore the relation between the positive rates of autoantibodies against beta(1) adrenergic receptor (beta1-receptor)and (M2-receptor) with urinary albumin excretion rate (UAER) in type 2 diabetes patients with refractory hypertension.</p><p><b>METHODS</b>Autoantibodies against beta(1)- and M(2)-receptor as well as autoantibodies were determined in type 2 diabetes patients with (n = 136) or without (n = 111) refractory hypertension, hypertensive patients without renal failure (n = 60) and healthy control subjects (n = 40, control) by ELISA.</p><p><b>RESULTS</b>The positive rates of the autoantibodies against beta1-receptors (44.9%) and M(2)-receptor (37.5%) in patients with type 2 diabetes with refractory hypertension were significantly higher than those in patients with type 2 diabetes without refractory hypertension (27.9% and 24.3%, respectively, all P < 0.05), in patients with hypertension without renal failure (11.7% and 15.0%, all P < 0.01) and in healthy controls (8.3% and 7.5%, all P < 0.01). In type 2 diabetes patients with refractory hypertension and renal failure (UAER > or = 200 microg/min), the positive rates of the autoantibodies against beta(1)-receptor (87.1%, 27/31) and against M(2)-receptor (67.7%, 21/31) were significantly higher than those in type 2 diabetes patients with refractory hypertension but without renal failure (UAER 20 - 199 microg /min, 46.7%, 28/60 and 41.7%, 25/60, respectively, all P < 0.05).</p><p><b>CONCLUSION</b>The serum beta(1)- and M (2)-receptor autoantibodies are positively associated with the UAER level and suggest that these autoantibodies against beta(1) and M(2)-receptor may play important roles in the pathogenesis of the type 2 diabetes with refractory hypertension.</p>
Subject(s)
Aged , Female , Humans , Male , Middle Aged , Albuminuria , Autoantibodies , Diabetes Mellitus, Type 2 , Allergy and Immunology , Hypertension , Allergy and Immunology , Receptor, Muscarinic M2 , Allergy and Immunology , Receptors, Adrenergic, beta-1 , Allergy and ImmunologyABSTRACT
The Fusion (F) and Haemagglutinin-Neuraminidase (HN) genes of Newcastle disease virus (NDV) and the glycoprotein B (gB) gene of infectious laryngothracheitis virus (ILTV) as well as a LacZ reporter gene were all inserted into a nonessential gene of fowlpox virus (FPV) 017 strain by homologous recombination. The NDV and ILTV genes were each under the control of a fowlpox virus immediate early/late promoter (LP2EP2) while the LacZ reporter gene expression cassette was regulated by a P11 late promoter. A recombinant FPV harboring the F, HN and gB genes as well as the LacZ gene, designated as rFPV-F/HN/gB/LacZ, was obtained after ten cycles of blue plaque purification. The presence of the NDV and ILTV genes was confirmed by PCR. The expression of the recombinant proteins in rFPV-F/HN/gB/LacZ were characterized by Western blot (F and gB proteins) and indirect immunofluorescence test (F, HN and gB proteins). The results demonstrated that all four foreign proteins, which were encoded within a 10 kb gene fragment, could be expressed authentically and efficiently. Compared to the parental virus, rFPV-F/HN/gB/LacZ showed no obvious difference with respect to virus replication and cytopathogenic effects in chicken embryo fibroblasts (CEF) cell culture. Overall, our work suggests that FPV can be a useful live virus vector for the expression of multi- foreign genes against multiple avian pathogens.
Subject(s)
Animals , Cloning, Molecular , Fibroblasts , Virology , Fowlpox virus , Genetics , Gene Expression , Genetic Engineering , Methods , HN Protein , Genetics , Herpesvirus 1, Gallid , Genetics , Physiology , Newcastle disease virus , Genetics , Physiology , Plasmids , Genetics , Transfection , Viral Envelope Proteins , Genetics , Viral Fusion Proteins , GeneticsABSTRACT
Objective To research the relationship between plasma osteoprotegerin (OPG) level and endothelium-dependent arterial dilation (EDAD) in type 2 diabetic patients.Methods The subjects included 40 newly diagnosed type 2 diabetic patients and 46 healthy subjects.Insulin therapy were then given to all diabetic patients for 6 months.Plasma OPG was measured by a sandwich ELISA method,and brachial artery diameter was determined by high resolution ultrasound at rest after reactive hyperemia and after sublingual glyceryl trinitrate (GTN).Results Plasma OPG level in diabetic patients before treatment was (3.44?0.52) ng/L,which was significantly higher than that in control (2.38?0.25 ) ng/L (P
ABSTRACT
PCR/ASO probes were applied to analyse the T-786C polymorphisms in 5′-flanking region of endothelial nitric oxide synthase(eNOS)gene in type 2 diabetic patients with or without nephropatby and healthy individuals.The results showed that the T-786C polymorphisms of eNOS gene seemed to be related to diabetic nephropathy in type 2 diabetes.